4.5 Article

Recovery of cardiac function following COVID-19-ECHOVID-19: a prospective longitudinal cohort study

Journal

EUROPEAN JOURNAL OF HEART FAILURE
Volume 23, Issue 11, Pages 1903-1912

Publisher

WILEY
DOI: 10.1002/ejhf.2347

Keywords

COVID-19; Recovery following COVID-19; Follow-up; Strain echocardiography

Funding

  1. Novo Nordisk Foundation
  2. Herlev and Gentofte Hospital
  3. Lundbeck foundation

Ask authors/readers for more resources

This study showed that right ventricular function tends to recover following COVID-19, while left ventricular function does not significantly improve post-recovery. Recovered COVID-19 patients have lower cardiac function measures compared to matched controls, indicating that both left and right ventricular function remain impaired.
Aims The degree of cardiovascular sequelae following COVID-19 remains unknown. The aim of this study was to investigate whether cardiac function recovers following COVID-19. Methods and results A consecutive sample of patients hospitalized with COVID-19 was prospectively included in this longitudinal study. All patients underwent an echocardiographic examination during hospitalization and 2 months later. All participants were successfully matched 1:1 with COVID-19-free controls by age and sex. A total of 91 patients were included (mean age 63 +/- 12 years, 59% male). A median of 77 days (interquartile range: 72-92) passed between the two examinations. Right ventricular (RV) function improved following resolution of COVID-19: tricuspid annular plane systolic excursion (TAPSE) (2.28 +/- 0.40 cm vs. 2.11 +/- 0.38 cm, P < 0.001) and RV longitudinal strain (RVLS) (25.3 +/- 5.5% vs. 19.9 +/- 5.8%, P < 0.001). In contrast, left ventricular (LV) systolic function assessed by global longitudinal strain (GLS) did not significantly improve (17.4 +/- 2.9% vs. 17.6 +/- 3.3%, P = 0.6). N-terminal pro-B-type natriuretic peptide decreased between the two examinations [177.6 (80.3-408.0) ng/L vs. 11.7 (5.7-24.0) ng/L, P < 0.001]. None of the participants had elevated troponins at follow-up compared to 18 (27.7%) during hospitalization. Recovered COVID-19 patients had significantly lower GLS (17.4 +/- 2.9% vs. 18.8 +/- 2.9%, P < 0.001 and adjusted P = 0.004), TAPSE (2.28 +/- 0.40 cm vs. 2.67 +/- 0.44 cm, P < 0.001 and adjusted P < 0.001), and RVLS (25.3 +/- 5.5% vs. 26.6 +/- 5.8%, P = 0.50 and adjusted P < 0.001) compared to matched controls. Conclusion Acute COVID-19 affected negatively RV function and cardiac biomarkers but recovered following resolution of COVID-19. In contrast, the observed reduced LV function during acute COVID-19 did not improve post-COVID-19. Compared to the matched controls, both LV and RV function remained impaired.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available